These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3244663)

  • 1. Formulation of vaccine adjuvant muramyldipeptides (MDP). 2. The thermal reactivity and pH of maximum stability of MDP compounds in aqueous solution.
    Powell MF; Foster LC; Becker AR; Lee W
    Pharm Res; 1988 Aug; 5(8):528-32. PubMed ID: 3244663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation of vaccine adjuvant muramyldipeptides (MDP). 1. Characterization of amorphous and crystalline forms of a muramyldipeptide analogue.
    Chan TW; Becker A
    Pharm Res; 1988 Aug; 5(8):523-7. PubMed ID: 3244662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the stability of muroctasin and degradation products built under extreme conditions.
    Moroi R; Yamazaki K; Hirota T; Watanabe S; Oki M; Toriyama M; Ichinohe A; Kataoka K
    Arzneimittelforschung; 1988 Jul; 38(7A):959-68. PubMed ID: 3190803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute and chronic polyarthritis induced by an aqueous form of 6-O-acyl and N-acyl derivatives of N-acetylmuramyl-L-alanyl-D-isoglutamine in euthymic rats and athymic nude rats.
    Kohashi O; Kohashi Y; Shigematsu N; Ozawa A; Kotani S
    Lab Invest; 1986 Sep; 55(3):337-46. PubMed ID: 3489128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced stability of codeine sulfate: effect of pH, buffer, and temperature on the degradation of codeine in aqueous solution.
    Powell MF
    J Pharm Sci; 1986 Sep; 75(9):901-3. PubMed ID: 3783462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of lidocaine in aqueous solution: effect of temperature, pH, buffer, and metal ions on amide hydrolysis.
    Powell MF
    Pharm Res; 1987 Feb; 4(1):42-5. PubMed ID: 3508528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parenteral peptide formulations: chemical and physical properties of native luteinizing hormone-releasing hormone (LHRH) and hydrophobic analogues in aqueous solution.
    Powell MF; Sanders LM; Rogerson A; Si V
    Pharm Res; 1991 Oct; 8(10):1258-63. PubMed ID: 1839059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cefuroxime hydrolysis kinetics and stability predictions in aqueous solution.
    Wang D; Notari RE
    J Pharm Sci; 1994 Apr; 83(4):577-81. PubMed ID: 8046618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
    Heymer B; Finger H; Wirsing CH
    Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficient genetically controlled formation of antibody to a synthetic antigen [poly(LTyr, LGlu)-poly(DLAla)- -poly(LLys)] covalently bound to a synthetic adjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Mozes E; Sela M; Chedid L
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4933-7. PubMed ID: 6776530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of pH, temperature, and buffers on the kinetics of ceftazidime degradation in aqueous solutions.
    Zhou M; Notari RE
    J Pharm Sci; 1995 May; 84(5):534-8. PubMed ID: 7658340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and immunoadjuvant activities of 2-acetamido-5-O-acetyl-6-O-acyl-2-deoxy-3-O-[(R)-2-propionyl-L-alanyl-D- isoglutamine]-D-glucofuranoses as potential prodrug forms of 6-O-Acyl Derivatives of N-acetylmuramyl dipeptide.
    Durette PL; Dorn CP; Friedman A; Schlabach A
    J Med Chem; 1982 Sep; 25(9):1028-33. PubMed ID: 7131480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereo-isomer specific induction of renal cell apoptosis by synthetic muramyl dipeptide (N-acetylmuramyl-L-alanyl-D-isoglutamine).
    Langford MP; Chen D; Welbourne TC; Redens TB; Ganley JP
    Mol Cell Biochem; 2002 Jul; 236(1-2):63-73. PubMed ID: 12190122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation kinetics of metronidazole in solution.
    Wang DP; Yeh MK
    J Pharm Sci; 1993 Jan; 82(1):95-8. PubMed ID: 8429500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of pramlintide degradation in aqueous solution as a function of temperature and pH.
    Kenley RA; Tracht S; Stepanenko A; Townsend M; L'Italien J
    AAPS PharmSciTech; 2000 Mar; 1(2):E7. PubMed ID: 14727840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation kinetics of L-glutamine in aqueous solution.
    Arii K; Kobayashi H; Kai T; Kokuba Y
    Eur J Pharm Sci; 1999 Oct; 9(1):75-8. PubMed ID: 10493999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatographic (HPLC) and HPLC-mass spectrometric (MS) analysis of the degradation of the luteinizing hormone-releasing hormone (LH-RH) antagonist RS-26306 in aqueous solution.
    Strickley RG; Brandl M; Chan KW; Straub K; Gu L
    Pharm Res; 1990 May; 7(5):530-6. PubMed ID: 2195493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability and degradation profiles of Spantide II in aqueous solutions.
    Kikwai L; Babu RJ; Kanikkannan N; Singh M
    Eur J Pharm Sci; 2006 Feb; 27(2-3):158-66. PubMed ID: 16266798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaerobic stability of aqueous physostigmine solution.
    Chen JL; Yeh MK; Chiang CH
    Drug Dev Ind Pharm; 2000 Sep; 26(9):1007-11. PubMed ID: 10914327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the stability of linezolid in aqueous solution and commonly used intravenous fluids.
    Taylor R; Sunderland B; Luna G; Czarniak P
    Drug Des Devel Ther; 2017; 11():2087-2097. PubMed ID: 28744100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.